Sickle cell disease trials in Oman

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  Where

  Muscat

  Age

  10 years to 65 years

  People

  192 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06975865
• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Muscat

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00
• Phase 3Taking people
  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Where

  Muscat

  Age

  12 years and over

  People

  510 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06612268 · EU 2023-509175-16-00
• Phase 2Taking people
  A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

  Where

  Muscat

  Age

  12 years to 16 years

  People

  27 worldwide

  Run by

  Forma Therapeutics, Inc.

  See details and how to joinNCT05953584
• Phase 4Taking people
  Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  Where

  Khoudh

  Age

  6 months to 100 years

  People

  130 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04657822 · EU 2024-510734-41-00